Cardinal Health Makes it Easier for Community Pharmacies to Help Patients Access, Improve Compliance with Specialty Medications
Cardinal Health has launched the Specialty Pharmacy Alliance, a new suite of services that make it easier for community pharmacies to improve their patients' access to and compliance with specialty medications, which usually require specialised handling, dispensing, administration and patient counseling services.
These medications are often high-cost and high-touch, and the patients who take them often need a great deal of support managing both the clinical and financial complexities of their specialty medication regimens.
Manufacturers of many specialty drugs — particularly those with relatively small patient populations — are increasingly implementing 'limited distribution' programmes, which specify that a specialty medication can only be dispensed by a small network of specialty pharmacies, which have demonstrated capabilities in providing complex patient care, nationwide. Doing so minimises the variability and cost of care, and makes it easier for manufacturers to collect patient intake and compliance data that is critical to tracking medication efficacy.
The Cardinal Health Specialty Pharmacy Alliance creates a cost-effective way for community pharmacies to provide their patients with access to the growing number of specialty medications. Community pharmacies can also utilise the Cardinal Health Specialty Pharmacy Alliance to provide their patients with access to the many support services required by specialty medications, while continuing to fill as many traditional prescriptions as possible at the local store level.
"During the next 5 years, sales of specialty drugs that are used to treat complex illnesses ranging from cancer and AIDS to hepatitis C and multiple sclerosis are expected to grow by at least 17% annually," said Ray Rede, vice president, Managed Care Relations, Community Specialty Pharmacy Network (CSPN). "As early at 2015, specialty drugs are expected to dominate the top 10 dispensed drug rankings. Given these projected growth rates, it's critically important that community pharmacists have access to resources that can help them serve the specialty medication needs of their patients."
Specialty Pharmacy Alliance accomplishes that goal by leveraging Cardinal Health's state-of-the-art Specialty Pharmacy, OncoSource Rx, which is located in Maryland, and accredited by URAC. Staffed by certified pharmacists and pharmacy technicians to support patient needs 24 hours-a-day, 7 days-a-week, 365 days-a-year, OncoSource Rx offers a broad range of patient-centric services. These services, available to any retail pharmacy in the United States, are designed to improve patient compliance with specialty drug regimens and to help patients better manage the clinical and financial complexities of these medications. This team of specialty drug experts can:
• Manage prior authorization and co-pay assistance — to help patients navigate the often complicated process of being approved by their pharmacy benefits manager (PBM) or medical benefit plan to receive a specific medication. OncoSource Rx can also help patients access financial resources to assist them with co-pays and other related financial issues.
• Dispense specialty medications and adjudicate related claims – when a specialty medication is available only through a limited distribution network and can't be filled at a retail pharmacy, OncoSource Rx can dispense the prescription, adjudicate the claim and mail the medication to the patient.
• Help retail pharmacies fulfill as many patient prescriptions as possible, at the local level — when the benefits investigation process indicates that a specialty medication can be dispensed by a retail pharmacy, OncoSource Rx will notify the community pharmacy and inform the patient that the prescription can be picked up there.
• Provide individualized patient care — including patient training on how to self-administer medications, how to manage complex medication adherence guidelines and how to manage related side effects.
• Work with the patient, PBM and the prescribing physician to order and process medication refills.
"Specialty Pharmacy Alliance aims to enhance the relationship between patients and their community pharmacies," said Jon Giacomin, president of US Pharmaceutical Distribution for Cardinal Health's Pharmaceutical Segment. "Our goal is to make it easier for retail pharmacies to provide their patients with convenient access to specialty medications and related support, while also reinforcing their role as their community's most accessible, most trusted local health care resource."
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance